This guide covers IVF with preimplantation genetic testing costs in Turkey for international patients. You will find detailed pricing for PGT-A aneuploidy screening, PGT-M monogenic disorder testing, and PGT-SR structural rearrangement analysis, along with success rate data, biopsy process details, and the factors that affect your total treatment cost.
Turkey offers advanced preimplantation genetic testing at significantly lower costs than Western Europe or North America. Leading Turkish fertility centers use next-generation sequencing (NGS) technology and have partnerships with international genetics laboratories.
Your IVF-PGT cost depends on the type of genetic testing, number of embryos biopsied, and whether additional IVF procedures are needed.
PGT pricing depends on the type of genetic test, number of embryos biopsied, and whether custom probe development is needed. The ranges below represent current market-level guidance for international patients.
| Test Type | What It Screens For | Estimated Cost Range | Key Price Variables |
|---|---|---|---|
| PGT-A (Aneuploidy Screening) | Extra or missing chromosomes (trisomy 21, monosomy X, etc.) | From €4,000 (IVF + PGT) | Number of embryos biopsied, NGS platform used, clinic lab partnership |
| PGT-M (Monogenic Disorders) | Specific single-gene conditions (CF, SCD, thalassemia, Huntington's) | From €5,500 (IVF + PGT) | Custom probe development cost, complexity of the genetic mutation, family testing |
| PGT-SR (Structural Rearrangements) | Balanced translocations, inversions, deletions in chromosomes | From €5,000 (IVF + PGT) | Type of rearrangement, number of embryos, specialized analysis requirements |
Mapa Health currently offers IVF with PGT-A starting from €4,000, including fertility specialist consultations, ovarian stimulation monitoring, egg retrieval, ICSI, embryo culture to blastocyst, trophectoderm biopsy, NGS genetic analysis, vitrification, accommodation, and VIP airport transfers. Final pricing confirmed after genetic counseling and treatment planning.
PGT-M cycles require additional time and cost for custom probe development. PGT-SR cases are quoted individually based on the specific chromosomal rearrangement.
PGT is typically priced per embryo biopsied, meaning the total cost varies based on how many blastocysts reach biopsy stage. The IVF cycle cost remains fixed, but the genetics laboratory fee scales with embryo count.
| Embryo Count | Typical Scenario | Indicative PGT-A Add-On Cost | Notes |
|---|---|---|---|
| 1-2 embryos | Low ovarian reserve, older patients, mini IVF | €800 - €1,200 | Lower testing cost but fewer chances of finding a euploid embryo |
| 3-5 embryos | Average IVF response, moderate egg yield | €1,200 - €1,800 | Good balance of cost vs diagnostic value; most common scenario |
| 6-8 embryos | Good ovarian response, younger patients | €1,800 - €2,500 | Higher per-cycle cost but excellent chance of finding euploid embryos |
| 8+ embryos | High responders, PCOS patients | €2,500+ | Maximum testing cost; surplus euploid embryos can be frozen for siblings |
PGT adds a significant cost layer to IVF treatment in all countries. Turkey's cost advantage is particularly pronounced for PGT cycles because both the IVF and genetics components are priced lower.
| Country | Typical IVF + PGT-A Cost | PGT-A Add-On Cost | Notes |
|---|---|---|---|
| Turkey | €4,000 - €7,000 | €1,000 - €2,500 | All-inclusive packages; NGS technology standard; competitive per-embryo pricing |
| United Kingdom | £7,000 - £12,000 | £2,000 - £4,000 | HFEA-regulated; PGT-M requires HFEA approval for specific conditions |
| United States | $15,000 - $25,000 | $3,000 - $6,000 | Widest availability; some clinics include PGT-A in standard IVF pricing |
| Spain | €6,000 - €10,000 | €2,000 - €4,000 | Popular European destination; strong genetics lab infrastructure |
PGT cycles involve more components than standard IVF. Budget for the IVF cycle, genetic testing, embryo freezing, and the subsequent frozen embryo transfer cycle.
All pricing serves as educational guidance. Your personalized IVF-PGT quote depends on the type of genetic testing, expected embryo count, and your specific clinical requirements.
IVF-PGT packages are more complex than standard IVF packages because they involve additional laboratory steps, a genetics laboratory partnership, and typically a two-stage process (IVF cycle + separate FET cycle).
Each type of preimplantation genetic testing serves a different clinical purpose. Understanding which test you need determines both the treatment approach and cost.
| Test Type | What It Detects | Who Benefits Most | Key Considerations |
|---|---|---|---|
| PGT-A | Whole chromosome gains or losses (aneuploidy) | Women over 37, recurrent miscarriage, repeated implantation failure, single embryo transfer preference | Most common PGT type; does not require advance custom probe; results in 2-3 weeks |
| PGT-M | Specific single-gene mutations (e.g., CF, SCD, thalassemia, BRCA) | Carriers of known genetic conditions wanting to prevent transmission to children | Requires custom probe development (4-8 weeks lead time); family member DNA samples may be needed |
| PGT-SR | Balanced/unbalanced translocations, inversions, large deletions | Patients with known chromosomal rearrangements causing recurrent miscarriage or infertility | Specialized analysis; higher proportion of embryos may be unbalanced; multiple cycles may be needed |
PGT is not necessary for every IVF patient. Understanding who benefits most helps you decide whether the additional cost and complexity are justified for your situation.
A fertility specialist who explains that PGT is not necessary for your case is helping you avoid unnecessary cost and complexity. This is a positive indicator of clinical integrity.
IVF with PGT is a two-phase process: the IVF cycle with embryo biopsy (first trip), followed by frozen embryo transfer after results (second trip or remote preparation).
Understanding PGT's limitations alongside its benefits helps you make a fully informed decision about genetic testing.
When comparing clinics for IVF with PGT, both the IVF laboratory and the genetics laboratory quality matter equally. Use this framework for evaluation.
These publicly verifiable references help you validate Mapa Health's service claims before requesting a private consultation.
Mapa Health's official contact page states that treatments are carried out at partner healthcare institutions holding the official health tourism authorization certificate issued by the Turkish Ministry of Health.
As of 15 March 2026, the public Trustpilot profile for mapahealth.com covers multiple treatment categories. Filter for fertility-specific experiences.
Selecting an IVF-PGT provider requires evaluating both embryology laboratory quality and genetics partnership strength.
Explore related fertility procedures for detailed pricing and treatment information.
Explore related fertility treatment pages for detailed pricing, candidacy, and success rate information.
This FAQ addresses the most common pricing, testing, and clinical questions that international patients ask before booking IVF with genetic testing in Istanbul.
IVF with PGT-A in Turkey starts from approximately €4,000 per cycle, including the IVF treatment and genetic testing. PGT-A adds €1,000-€2,500 to the base IVF cost depending on the number of embryos tested. PGT-M requires additional custom probe development costing €1,500-€3,000, while PGT-SR adds €1,500-€2,500. The frozen embryo transfer cycle after results is typically quoted separately at €800-€1,500.
PGT-A (preimplantation genetic testing for aneuploidy) screens all chromosomes for extra or missing copies, which is the most common cause of miscarriage and IVF failure. PGT-M tests for specific known single-gene disorders like cystic fibrosis or sickle cell disease. PGT-SR detects structural chromosomal rearrangements such as balanced translocations. Each test type requires different laboratory approaches and has different cost structures.
PGT-A improves per-transfer success rates by selecting only chromosomally normal embryos, reducing the chance of transferring an embryo that would result in miscarriage or failed implantation. For women over 37, the improvement is most significant because a higher proportion of their embryos are aneuploid. However, PGT does not increase the total number of viable embryos you produce; it improves the efficiency of selecting the right one for transfer.
PGT adds approximately 2-4 weeks for results after embryo biopsy, plus the time needed for a frozen embryo transfer cycle. The total process from IVF start to pregnancy test is typically 6-10 weeks, compared to 3-4 weeks for standard IVF. This is because embryos are frozen after biopsy while results are analyzed, requiring a separate FET cycle for transfer.
Trophectoderm biopsy removes 5-10 cells from the outer layer of the blastocyst (which becomes the placenta) without touching the inner cell mass (which becomes the baby). When performed by experienced embryologists, embryo survival rates after biopsy and subsequent thawing exceed 95%. Current evidence does not show increased birth defect rates in PGT-tested embryos.
The more blastocysts available for testing, the higher the chance of finding at least one euploid embryo. Ideally, 4-6 blastocysts should reach biopsy stage. For women over 40, approximately 20-40% of embryos may be euploid, so 5+ blastocysts are preferred. With only 1-2 embryos, PGT may leave you with no viable options for transfer if both are aneuploid.
If all embryos are aneuploid, your specialist will discuss options: another IVF cycle to create more embryos for testing, considering transfer of mosaic embryos (with mixed normal/abnormal cells) after thorough genetic counseling, using donor eggs with a younger donor to increase euploid rates, or exploring other family-building approaches. The probability of all embryos being aneuploid increases with maternal age.
No. PGT-A is most beneficial for women over 37, patients with recurrent pregnancy loss, repeated implantation failure, or those who strongly prefer single embryo transfer with high confidence. For younger patients with good prognosis, PGT-A adds cost without necessarily improving cumulative live birth rates. PGT-M is specifically recommended when either partner carries a known genetic condition they want to avoid passing to children.
No. PGT-A detects whole chromosome abnormalities but does not identify single-gene disorders, microdeletions, or epigenetic conditions. PGT-M can test for specific known mutations but requires advance preparation and cannot screen for conditions not already identified in the family. Prenatal testing (CVS or amniocentesis) during pregnancy is still recommended for comprehensive genetic screening even after PGT.
A mosaic embryo has a mixture of chromosomally normal and abnormal cells. PGT detects mosaicism in approximately 10-20% of biopsied embryos. Low-level mosaic embryos can be transferred after genetic counseling, with studies showing lower but still meaningful pregnancy rates. The decision requires careful discussion about potential risks and the specific chromosomes involved. Not all mosaic patterns carry the same level of concern.
Share your fertility history and genetic concerns to receive an initial assessment, PGT type recommendation, and estimated pricing. Our genetic counselor can help you understand whether PGT is clinically indicated for your situation.